Cancer incidence in Canada: trends and projections (1983-2032) - HPCDP: Volume 35, Supplement 1, Spring 2015

Cancer incidence in Canada: trends and projections (1983-2032)

L. Xie, MSc; R. Semenciw, MSc; L. Mery, MSc

https://doi.org/10.24095/hpcdp.35.S1.02

This article has been peer reviewed.

Author reference:

Surveillance and Epidemiology Division, Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario, Canada

Correspondence: Lin Xie, Surveillance and Epidemiology Division, Centre for Chronic Disease Prevention, Public Health Agency of Canada, 785 Carling Avenue, AL 6807A, Ottawa, ON K1A 0K9; Tel.: 613-952-5176; Fax: 613-960-0944; Email: lin.xie@phac-aspc.gc.ca

Table of contents

• List of tables
• List of figures
• Preface
  H. Morrison
• Purpose and intended audience
• Executive Summary
• Chapter 1: Introduction
• Chapter 2: Data and Methods
  • 2.1 Data
  • 2.2 Methods
    • 2.2.1 Projection methods
      • 2.2.1.1 Projection models
      • 2.2.1.2 Comparison of models
      • 2.2.1.3 Projection validation and adjustment
      • 2.2.1.4 Selected models by cancer category
    • 2.2.2 Other analysis methods
      • 2.2.2.1 Joinpoint regression analysis
      • 2.2.2.2 Contribution of change in cancer risk, population growth and population age structure to incidence trend
  • 2.3 Presentation of results
• Chapter 3: Overview of Observed and Projected Status of All Cancers
  • Recent changes in observed cancer incidence rates
  • Overall (historic and projected) trends
  • Trends by age
  • Trends by sex
  • Trends by geographical region
  • Observed most common cancers by sex and age
  • Projected most common cancers by sex and age
• Chapter 4: Projections by Cancer Site
  1. Oral cancer
  2. Esophagus cancer
  3. Stomach cancer
  4. Colorectal cancer
  5. Liver cancer
  6. Pancreas cancer
  7. Larynx cancer
  8. Lung cancer
  9. Melanoma
  10. Breast cancer (in females)
  11. Cervix cancer
  12. Cancer of the body of the uterus
  13. Ovarian cancer
  14. Prostate cancer
  15. Testis cancer
  16. Kidney cancer
  17. Bladder cancer
  18. Central nervous system cancers
  19. Thyroid cancer
  20. Hodgkin lymphoma
  21. Non-Hodgkin lymphoma
  22. Multiple myeloma
  23. Leukemia
  24. All other cancers
• Chapter 5: Discussion
  • Main findings
  • Data quality issues
  • Comments on methods and results
  • Implications for future cancer control strategies
• Acknowledgements
• References
• Abbreviations

List of tables

• TABLE 2.1 Cancer definitions for incidence
• TABLE 2.2 1991 Canadian standard population
• TABLE 2.3 Projection models for rare cancers or in small areas by cancer type, sex and geographical area
• TABLE 3.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), all cancers, males, Canada, 2003-2032
• TABLE 3.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), all cancers, females, Canada, 2003-2032
• TABLE 3.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), all cancers, males, Canada, 2003-2032
• TABLE 3.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), all cancers, females, Canada, 2003-2032
• TABLE 4.1.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), oral cancer, males, Canada, 2003-2032
• TABLE 4.1.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), oral cancer, females, Canada, 2003-2032
• TABLE 4.1.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), oral cancer, males, Canada, 2003-2032
• TABLE 4.1.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), oral cancer, females, Canada, 2003-2032
• TABLE 4.2.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), esophagus cancer, males, Canada, 2003-2032
• TABLE 4.2.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), esophagus cancer, females, Canada, 2003-2032
• TABLE 4.2.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), esophagus cancer, males, Canada, 2003-2032
• TABLE 4.2.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), esophagus cancer, females, Canada, 2003-2032
• TABLE 4.3.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), stomach cancer, males, Canada, 2003-2032
• TABLE 4.3.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), stomach cancer, females, Canada, 2003-2032
• TABLE 4.3.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), stomach cancer, males, Canada, 2003-2032
• TABLE 4.3.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), stomach cancer, females, Canada, 2003-2032
• TABLE 4.4.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), cancers of colon and rectum, males, Canada, 2003-2032
• TABLE 4.4.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), cancers of colon and rectum, females, Canada, 2003-2032
• TABLE 4.4.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), cancers of colon and rectum, males, Canada, 2003-2032
• TABLE 4.4.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), cancers of colon and rectum, females, Canada, 2003-2032
• TABLE 4.5.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), liver cancer, males, Canada, 2003-2032
• TABLE 4.5.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), liver cancer, females, Canada, 2003-2032
• TABLE 4.5.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), liver cancer, males, Canada, 2003-2032
• TABLE 4.5.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), liver cancer, females, Canada, 2003-2032
• TABLE 4.6.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), pancreas cancer, males, Canada, 2003-2032
• TABLE 4.6.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), pancreas cancer, females, Canada, 2003-2032
• TABLE 4.6.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), pancreas cancer, males, Canada, 2003-2032
• TABLE 4.6.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), pancreas cancer, females, Canada, 2003-2032
• TABLE 4.7.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), larynx cancer, males, Canada, 2003-2032
• TABLE 4.7.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), larynx cancer, females, Canada, 2003-2032
• TABLE 4.7.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), larynx cancer, males, Canada, 2003-2032
• TABLE 4.7.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), larynx cancer, females, Canada, 2003-2032
• TABLE 4.8.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), lung cancer, males, Canada, 2003-2032
• TABLE 4.8.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), lung cancer, females, Canada, 2003-2032
• TABLE 4.8.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), lung cancer,males, Canada, 2003-2032
• TABLE 4.8.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), lung cancer, females, Canada, 2003-2032
• TABLE 4.9.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), melanoma, males, Canada, 2003-2032
• TABLE 4.9.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), melanoma, females, Canada, 2003-2032
• TABLE 4.9.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), melanoma, males, Canada, 2003-2032
• TABLE 4.9.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), melanoma, females, Canada, 2003-2032
• TABLE 4.10.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), breast cancer, females, Canada, 2003-2032
• TABLE 4.10.2 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), breast cancer, females, Canada, 2003-2032
• TABLE 4.11.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), cervix cancer, Canada, 2003-2032
• TABLE 4.11.2 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), cervix cancer, Canada, 2003-2032
• TABLE 4.12.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), cancer of the body of the uterus, Canada, 2003-2032
• TABLE 4.12.2 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), cancer of the body of the uterus, Canada, 2003-2032
• TABLE 4.13.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), ovarian cancer, Canada, 2003-2032
• TABLE 4.13.2 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), ovarian cancer, Canada, 2003-2032
• TABLE 4.14.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), prostate cancer, Canada, 2003-2032
• TABLE 4.14.2 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), prostate cancer, Canada, 2003-2032
• TABLE 4.15.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), testis cancer, Canada, 2003-2032
• TABLE 4.15.2 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), testis cancer, Canada, 2003-2032
• TABLE 4.16.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), kidney cancer, males, Canada, 2003-2032
• TABLE 4.16.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), kidney cancer, females, Canada, 2003-2032
• TABLE 4.16.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), kidney cancer, males, Canada, 2003-2032
• TABLE 4.16.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), kidney cancer, females, Canada, 2003-2032
• TABLE 4.17.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), bladder cancer, males, Canada, 2003-2032
• TABLE 4.17.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), bladder cancer, females, Canada, 2003-2032
• TABLE 4.17.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), bladder cancer, males, Canada, 2003-2032
• TABLE 4.17.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), bladder cancer, females, Canada, 2003-2032
• TABLE 4.18.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), central nervous system cancers, males, Canada, 2003-2032
• TABLE 4.18.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), central nervous system cancers, females, Canada, 2003-2032
• TABLE 4.18.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), central nervous system cancers, males, Canada, 2003-2032
• TABLE 4.18.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), central nervous system cancers, females, Canada, 2003-2032
• TABLE 4.19.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), thyroid cancer, males, Canada, 2003-2032
• TABLE 4.19.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), thyroid cancer, females, Canada, 2003-2032
• TABLE 4.19.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), thyroid cancer, males, Canada, 2003-2032
• TABLE 4.19.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), thyroid cancer, females, Canada, 2003-2032
• TABLE 4.20.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), Hodgkin lymphoma, males, Canada, 2003-2032
• TABLE 4.20.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), Hodgkin lymphoma, females, Canada, 2003-2032
• TABLE 4.20.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), Hodgkin lymphoma, males, Canada, 2003-2032
• TABLE 4.20.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), Hodgkin lymphoma, females, Canada, 2003-2032
• TABLE 4.21.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), non-Hodgkin lymphoma, males, Canada, 2003-2032
• TABLE 4.21.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), non-Hodgkin lymphoma, females, Canada, 2003-2032
• TABLE 4.21.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), non-Hodgkin lymphoma, males, Canada, 2003-2032
• TABLE 4.21.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), non-Hodgkin lymphoma, females, Canada, 2003-2032
• TABLE 4.22.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), multiple myeloma, males, Canada, 2003-2032
• TABLE 4.22.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), multiple myeloma, females, Canada, 2003-2032
• TABLE 4.22.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), multiple myeloma, males, Canada, 2003-2032
• TABLE 4.22.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), multiple myeloma, females, Canada, 2003-2032
• TABLE 4.23.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), leukemia, males, Canada, 2003-2032
• TABLE 4.23.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), leukemia, females, Canada, 2003-2032
• TABLE 4.23.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), leukemia, males, Canada, 2003-2032
• TABLE 4.23.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), leukemia, females, Canada, 2003-2032
• TABLE 4.24.1 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), all other cancers, males, Canada, 2003-2032
• TABLE 4.24.2 Observed (2003-2007) and projected average annual new cases by age and province/territories combined (TC), all other cancers, females, Canada, 2003-2032
• TABLE 4.24.3 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), all other cancers, males, Canada, 2003-2032
• TABLE 4.24.4 Observed (2003-2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), all other cancers, females, Canada, 2003-2032
• TABLE 5.1 Changes in average annual new cases and age-standardized incidence rates (ASIRs) for cancers by sex, Canada, from 2003-2007 to 2028-2032
• TABLE 5.2 Median of absolute relative difference between observed and projected number of average annual cancer cases in 1992-2010, Canada
• TABLE 5.3 Prevalence of hysterectomy in women aged 40 and older by geographical area, Canada, 2003

List of figures

• FIGURE 1.1 Historic and projected growth in average annual population in Canada by age, 1983-2032
• FIGURE 3.1 Annual percent changes in age-standardized incidence rates (1998-2007) for selected cancers, males, Canada
• FIGURE 3.2 Annual percent changes in age-standardized incidence rates (1998-2007) for selected cancers, females, Canada
• FIGURE 3.3 Average annual new cases and age-standardized incidence rates (ASIRs) for all cancers, Canada, 1983-2032
• FIGURE 3.4 Trends in average annual new cases for all cancers and ages, attributed to cancer risk, population growth, and aging population, Canada, 1983-2032
• FIGURE 3.5 Historic and projected growth in average annual population (pop) and in average annual incidence cases of all cancers in Canada by age, 1983-2032
• FIGURE 3.6 Age-standardized incidence rates (ASIRs) for all cancers by age group, Canada, 1983-2032
• FIGURE 3.7 Age-standardized incidence rates (ASIRs) by region, all cancers, 1983- 2032
• FIGURE 3.8 Most common newly diagnosed cancers in Canada, 1983-1987
• FIGURE 3.9 Most common newly diagnosed cancers in Canada, 2003-2007
• FIGURE 3.10 Projected most common newly diagnosed cancers in Canada, 2028-2032
• FIGURE 4.1.1 Age-standardized incidence rates (ASIRs) by region, oral cancer, 1983-2032
• FIGURE 4.1.2 Age-standardized incidence rates (ASIRs) for oral cancer by age group, Canada, 1983-2032
• FIGURE 4.2.1 Age-standardized incidence rates (ASIRs) by region, esophagus cancer, 1983-2032
• FIGURE 4.2.2 Age-standardized incidence rates (ASIRs) for esophagus cancer by age group, Canada, 1983-2032
• FIGURE 4.3.1 Age-standardized incidence rates (ASIRs) by region, stomach cancer, 1983-2032
• FIGURE 4.3.2 Age-standardized incidence rates (ASIRs) for stomach cancer by age group, Canada, 1983-2032
• FIGURE 4.4.1 Age-standardized incidence rates (ASIRs) by region, colorectal cancer, 1983-2032
• FIGURE 4.4.2 Age-standardized incidence rates (ASIRs) for colorectal cancer by age group, Canada, 1983-2032
• FIGURE 4.5.1 Age-standardized incidence rates (ASIRs) by region, liver cancer, 1983-2032
• FIGURE 4.5.2 Age-standardized incidence rates (ASIRs) for liver cancer by age group, Canada, 1983-2032
• FIGURE 4.6.1 Age-standardized incidence rates (ASIRs) by region, pancreas cancer, 1983-2032
• FIGURE 4.6.2 Age-standardized incidence rates (ASIRs) for pancreas cancer by age group, Canada, 1983-2032
• FIGURE 4.7.1 Age-standardized incidence rates (ASIRs) for larynx cancer, Canada, 2003-2007
• FIGURE 4.7.2 Age-standardized incidence rates (ASIRs) by region, larynx cancer, 1983-2032
• FIGURE 4.7.3 Age-standardized incidence rates (ASIRs) for larynx cancer by age group, Canada, 1983-2032
• FIGURE 4.8.1 Age-standardized incidence rates (ASIRs) by region, lung cancer, 1983-2032
• FIGURE 4.8.2 Age-standardized incidence rates (ASIRs) for lung cancer by age group, Canada, 1983-2032
• FIGURE 4.8.3 Age-standardized incidence rates (ASIRs) with and without adjustments for smoking prevalence rates, lung cancer, Canada, 1983-2032
• FIGURE 4.9.1 Age-standardized incidence rates (ASIRs) by region, melanoma, 1983-2032
• FIGURE 4.9.2 Age-standardized incidence rates (ASIRs) for melanoma by age group, Canada, 1983-2032
• FIGURE 4.10.1 Age-standardized incidence rates (ASIRs) by region, breast cancer, females, 1983-2032
• FIGURE 4.10.2 Age-standardized incidence rates (ASIRs) for breast cancer by age group, females, Canada, 1983-2032
• FIGURE 4.11.1 Age-standardized incidence rates (ASIRs) by region, cervix cancer, 1983-2032
• FIGURE 4.11.2 Age-standardized incidence rates (ASIRs) for cervix cancer by age group, Canada, 1983-2032
• FIGURE 4.12.1 Age-standardized incidence rates (ASIRs) by region, cancer of body of uterus, 1983-2032
• FIGURE 4.12.2 Age-standardized incidence rates (ASIRs) for cancer of body of uterus by age group, Canada, 1983-2032
• FIGURE 4.13.1 Age-standardized incidence rates (ASIRs) by region, ovarian cancer, 1983-2032
• FIGURE 4.13.2 Age-standardized incidence rates (ASIRs) for ovarian cancer by age group, Canada, 1983-2032
• FIGURE 4.14.1 Age-standardized incidence rates (ASIRs) by region, prostate cancer, 1983-2032
• FIGURE 4.14.2 Age-standardized incidence rates (ASIRs) for prostate cancer by age group, Canada, 1983-2032
• FIGURE 4.14.3 Comparison of projected age-standardized incidence rates (ASIRs) derived from the two models by region, prostate cancer, 2008-2017
• FIGURE 4.15.1 Age-specific incidence rates of testis cancer, Canada, 2003-2007 (from average annual counts)
• FIGURE 4.15.2 Age-standardized incidence rates (ASIRs) by region, testis cancer, 1983-2032
• FIGURE 4.15.3 Age-standardized incidence rates (ASIRs) for testis cancer by age group, Canada, 1983-2032
• FIGURE 4.16.1 Age-standardized incidence rates (ASIRs) by region, kidney cancer, 1983-2032
• FIGURE 4.16.2 Age-standardized incidence rates (ASIRs) for kidney cancer by age group, Canada, 1983-2032
• FIGURE 4.17.1 Age-standardized incidence rates (ASIRs) by region, bladder cancer, 1983-2032
• FIGURE 4.17.2 Age-standardized incidence rates (ASIRs) for bladder cancer by age group, Canada, 1983-2032
• FIGURE 4.18.1 Age-specific incidence rates of central nervous system cancer, Canada, 2003-2007 (from average annual counts)
• FIGURE 4.18.2 Age-standardized incidence rates (ASIRs) by region, central nervous system cancer, 1983-2032
• FIGURE 4.18.3 Age-standardized incidence rates (ASIRs) for central nervous system cancer by age group, Canada, 1983-2032
• FIGURE 4.19.1 Age-standardized incidence rates (ASIRs) by region, thyroid cancer, 1983-2032
• FIGURE 4.19.2 Age-standardized incidencerates (ASIRs) for thyroid cancer by age group, Canada, 1983-2032
• FIGURE 4.20.1 Age-specific incidence rates of Hodgkin lymphoma, Canada, 2003-2007 (from average annual counts)
• FIGURE 4.20.2 Age-standardized incidence rates (ASIRs) by region, Hodgkin lymphoma, 1983-2032
• FIGURE 4.20.3 Age-standardized incidence rates (ASIRs) for Hodgkin lymphoma by age group, Canada, 1983-2032
• FIGURE 4.21.1 Age-standardized incidence rates (ASIRs) by region, non-Hodgkin lymphoma, 1983-2032
• FIGURE 4.21.2 Age-standardized incidence rates (ASIRs) for non-Hodgkin lymphoma by age group, Canada, 1983-2032
• FIGURE 4.22.1 Age-standardized incidence rates (ASIRs) by region, multiple myeloma, 1983-2032
• FIGURE 4.22.2 Age-standardized incidence rates (ASIRs) for multiple myeloma by age group, Canada, 1983-2032
• FIGURE 4.23.1 Age-specific incidence rates of leukemia, Canada, 2003-2007 (from average annual counts)
• FIGURE 4.23.2 Age-standardized incidence rates (ASIRs) by region, leukemia, 1983-2032
• FIGURE 4.23.3 Age-standardized incidence rates (ASIRs) for leukemia by age group, Canada, 1983-2032
• FIGURE 4.24.1 Age-standardized incidence rates (ASIRs) by region, all other cancers, 1983-2032
• FIGURE 4.24.2 Age-standardized incidence rates (ASIRs) for all other cancers by age group, Canada, 1983-2032